Skip to content
Thursday, November 12, 2026
Explore the latest in UK technology, digital trends, and in…

Zimbabwe Declines ‘Unbalanced’ US Healthcare Assistance Package Over Information Apprehensions

Medical aid illustration
The proposed American financial assistance was intended for programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has declined a major American healthcare agreement worth $367m (£272m) over five years because of Washington's request for sensitive data.

The decision came to light after a official document from December was leaked, indicating that President Emmerson Mnangagwa believed the agreement was "unbalanced".

A government spokesman later clarified that the US was seeking biological samples for research and profit while refused to guarantee the benefits from any future treatments.

"We are forced to start the challenging and unfortunate process of winding down our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy said the US had donated more than $1.9bn as health assistance to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has called for more negotiations to secure a agreement agreeable to both sides so the country's critical HIV programme can continue.

Wider Implications

Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a high court suspended a similar health funding agreement following legal challenges were filed about the security of Kenyans' health data.

After resuming office last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).

The agency had managed aid for the US government, but Trump argued its spending was "wasteful" and his administration was pursuing direct bilateral deals to boost openness and accountability.

According to reports, Sixteen nations in Africa have so far agreed to similar health pacts, representing more than $18.3bn in committed funds.

Specifics of the Rejected Deal

This assistance for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this collaboration could have provided significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment through American-funded programmes," the Ambassador commented.

However, government spokesperson Nick Mangwana said the proposed deal was "unequal".

"The proposal required Zimbabwe to share its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any medical innovations – like new medicines or tests – that could result from that provided information," his statement read.

"Effectively, our country would supply the basic resources for scientific discovery without any certainty that the end products would be accessible to our people if a new disease outbreak emerge."

Sovereignty and International Frameworks

He also said that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were undermining systems previously established via the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to deal with future global health emergencies.

"This system is intended to guarantee that when a country contributes its samples, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to create them."

These objections regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We encourage continued dialogue with our American counterparts on how subsequent co-operation could be designed in a way that respects the independence and dignity of each country."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but recommended that negotiations need to persist given that much of the nation's Aids initiatives relied on foreign aid.

"In cases where specific concerns arise, such as those involving data governance or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," it said.

This impasse highlights the complex challenges between accepting vital international aid and protecting local interests in an ever more data-driven world.

MJ
About the author

Miss Jessica Boyd

A digital strategist and tech writer based in London, specializing in emerging technologies and startup ecosystems across the UK.

StarCore Portal

Type to search articles.